Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05013632 · ClinicalTrials.gov registry record
COVID-19 International Drug Pregnancy Registry
A clinical trial of Covid19, sponsored by Pregistry.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05013632 is a study of Covid19 that is actively recruiting participants, run by Pregistry. The registered enrollment target is 2,000 participants, below the 2,681-participant average among 94 other Covid19 trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05013632, a study of Covid19, is actively recruiting participants, sponsored by Pregistry.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the COVID-19 International Drug Pregnancy Registry (COVID-PR) is to evaluate obstetric, neonatal, and infant outcomes among women treated with monoclonal antibodies or antiviral drugs indicated for mild, moderate, or severe COVID-19 from the first day of the last menstrual period (LMP) to end of pregnancy. For monoclonal antibodies, the exposure period also includes 90 days prior to the first day of the LMP.
Conditions Studied
Interventions
- DRUG Antiviral Agents
- DRUG Monoclonal antibody
Study Locations (1)
California
- Pregistry - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05013632
The ClinicalTrials.gov registry entry for NCT05013632 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,681-participant average among 94 other Covid19 trials with a reported enrollment target (25% lower). The listed sponsor is Pregistry, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 2 interventions - of which Antiviral Agents is the first listed.
NCT05013632 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05013632 about?
NCT05013632 is a clinical study titled "COVID-19 International Drug Pregnancy Registry". The objective of the COVID-19 International Drug Pregnancy Registry (COVID-PR) is to evaluate obstetric, neonatal, and infant outcomes among women treated with monoclonal antibodies or antiviral drugs indicated for mild, moderate, or severe COVID-19 from the first day of the last menstrual period (L...
What is the current status of trial NCT05013632?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2021-12-01. Estimated completion is 2027-09-30.
What conditions does trial NCT05013632 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT05013632?
The interventions under investigation include: Antiviral Agents (DRUG), Monoclonal antibody (DRUG).
Who is sponsoring clinical trial NCT05013632?
This trial is sponsored by Pregistry, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05013632 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Immune Activation in COVID-19
RECRUITING · Phase 2
-
Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure
RECRUITING · Phase 2
-
COVID-19 Vaccines International Pregnancy Exposure Registry
RECRUITING
-
COVID-19 Survivorship Registry
RECRUITING
-
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
RECRUITING · Phase 3
-
Conversations You Want About Corona Virus Disease (COVID-19)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.